HOME>Research&Development>Clinical Trial Information

Clinical Trial Information

For information on the clinical trials that our company conducts both domestically in Japan and overseas, and for which publication in international medical journals is scheduled, clinical trial information is registered on ClinicalTrials.gov (the website run by the United States National Library of Medicine), EU Clinical Trials Register (the website run by European Medicines Agency), or JapicCTI (the website run by the Japan Pharmaceutical Information Center).

Links:
ClinicalTrials.gov
Japan Pharmaceutical Information Center
EU Clinical Trials Register

Please use the links provided below to view our company listing on ClinicalTrials.gov.

  • RSS
  • About RSS

Prev.20 | 1 | 2 | 3 | 4 | 5 | 6 | Next 20

ClinicalTrials.gov ID NCT03570957 (2018/6 Entry)
Study Title A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
ClinicalTrials.gov ID NCT03541200 (2018/5 Entry)
Study Title Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms
ClinicalTrials.gov ID NCT03507738 (2018/5 Entry)
Study Title Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria
ClinicalTrials.gov ID NCT03507738 (2018/4 Entry)
Study Title Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
ClinicalTrials.gov ID NCT03461146 (2018/3 Entry)
Study Title Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
ClinicalTrials.gov ID NCT03439137 (2018/2 Entry)
Study Title Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
ClinicalTrials.gov ID NCT03436693 (2018/2 Entry)
Study Title Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
ClinicalTrials.gov ID NCT03402386 (2018/1 Entry)
Study Title Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
ClinicalTrials.gov ID NCT03346538 (2018/9 Update)※This study has been terminated.
Study Title Dose Finding Study of MCI-186 in Acute Ischemic Stroke
ClinicalTrials.gov ID NCT03329196 (2017/11 Entry)
Study Title Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
ClinicalTrials.gov ID NCT03291067 (2018/11 Update)※This study has been completed.
Study Title MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
ClinicalTrials.gov ID NCT03245008 (2017/8 Entry)
Study Title Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain
ClinicalTrials.gov ID NCT03188692 (2017/6 Update)
Study Title Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
ClinicalTrials.gov ID NCT03176771 (2017/6 Update)
Study Title Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
ClinicalTrials.gov ID NCT03172598 (2018/8 Update)※This study has been completed.
Study Title Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy
ClinicalTrials.gov ID NCT02992925 (2016/12 Entry)
Study Title Phase 3 Study of BK1310 in Healthy Infants
ClinicalTrials.gov ID NCT02923154 (2016/10 Entry)
Study Title Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
ClinicalTrials.gov ID NCT02924064 (2018/11 Update)※This study has been completed.
Study Title Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02916706(2018/11 Update)※This study has been completed.
Study Title Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov ID NCT02803268(2017/2 Update)※This study has been completed.
Study Title A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Prev.20 | 1 | 2 | 3 | 4 | 5 | 6 | Next 20

Research&Development

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide